(Q58416097)

English

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group

article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

0 references

1 reference

based on heuristic

inferred from title

acute promyelocytic leukemia

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Christine Chomienne

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

19

object named as

P Fenaux

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

European APL Group

21

object named as

European APL Group

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

C Callens

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

J-M Cayuela

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

E Raffoux

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

S de Botton

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

X Thomas

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

A Guerci

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

N Fegueux

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

A Pigneux

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

A-M Stoppa

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

T Lamy

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

F Rigal-Huguet

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

A Vekhoff

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

S Meyer-Monard

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

A Ferrand

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

H Dombret

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1153-1160

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Flt3 mutations and leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

FLT3-TKD mutation in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Internal tandem duplications of Flt3 gene (Flt3/ITD) predicts a poor post-remission outcome in adult patients with acute non-promyelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

FLT3 mutation and response to intensive chemotherapy in young adult and elderly patients with normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

21 January 2018

Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of FLT3 ITD and D835 mutations in AML patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

7 January 2021

based on heuristic

inferred from DOI database lookup

Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, Japan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

7 January 2021

based on heuristic

inferred from DOI database lookup

FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic structure of human FLT3: implications for mutational analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

7 January 2021

based on heuristic

inferred from DOI database lookup

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency of RAS and p53 mutations in acute promyelocytic leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of FLT3-ITD and D835 activating point mutations in relapsing acute myeloid leukemia and response to salvage therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403790

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403790

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15889156%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58416097&oldid=2213835837"